Is Entero Healthcare Solutions (ENTERO) overvalued or fairly valued?

MarketChacha shows Entero Healthcare Solutions's valuation in context — a forward P/E of about 22.5, a price-to-book of about 3.2 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is Entero Healthcare Solutions's revenue?

Entero Healthcare Solutions reported revenue of ₹6,591 Cr for FY2026, with net profit of ₹115 Cr, per official filings.

What is the share price of Entero Healthcare Solutions (ENTERO)?

Entero Healthcare Solutions last traded at ₹1,239.30 (+4.2% on the day), as of 7/22/2026 — a delayed quote shown for education, not investment advice.

Entero Healthcare Solutions

ENTERO · NSE · Healthcare · India

₹1,239.30+4.2%

Delayed · as reported by Yahoo Finance · as of Jul 22, 2026, 10:00 AM

Snapshot

TickerENTERO

ExchangeNSE

SectorHealthcare

IndustryMedical Distribution

CountryIndia

HeadquartersMumbai, India

Market cap₹5,394 Cr

P/B3.2

Volume1.05L

Websitewww.enterohealthcare.com

Filings tracked0

About Entero Healthcare Solutions

Entero Healthcare Solutions Limited engages in the distribution and marketing of pharmaceutical, surgical products and other allied services in India. The company involved in the distribution of generic formulations, active pharmaceutical ingredients, surgical consumables, rehabilitation products and devices, over the counter medical products, nutraceuticals, biosimilars, and biologics. It also provides nebulizers, personal protective, hygiene and surgical consumable products, homecare medical devices, gloves and mobility equipment, digital thermometers. In addition, the company offers healthcare products, including pharmaceutical and nutraceutical products, vaccines, medical devices, such as orthopaedic implants and coronary stents, and hospital consumables comprising examination and surgical gloves, syringes, needles and sutures to hospitals, retail pharmacies, healthcare product manufacturers, and healthcare clinics. Entero Healthcare Solutions Limited was incorporated in 2018 and is based in Mumbai, India.

Profile as reported by Yahoo Finance.

Who owns it

Promoters65.9%
Institutions15.0%
Public & other19.1%

23 institutional holders

As reported by Yahoo Finance. Promoter pledge is not included here — that comes from exchange shareholding filings.

Forensic scorecard

No major accounting red flags in the fundamentals we have — profit is backed by cash and returns look healthy.

Net margin trend1.0% → 1.7%

Margin has held broadly steady over the period — stable profitability.

Computed by MarketChacha from reported figures (Yahoo Finance). Education, not a rating or recommendation.

What's expected next

Next fiscal year

Rev ₹9,762 Cr · EPS 55.13

Est. earnings growth +46.0%

Analyst consensus estimates — not the company's own guidance. As reported by Yahoo Finance.

₹944.0052-wk range₹1,390.00

Delayed · as reported by Yahoo Finance

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: Yahoo Finance

Annual

Quarterly · last 4

Market cap

₹5,394 Cr

Day change

+4.2%

Fwd P/E

22.5

P/B

3.2

Beta

-0.61

Revenue (FY2026)

₹6,591 Cr

Net margin

1.7%

Revenue CAGR (2y)

+29.6%

Net profit (FY2026)

₹115 Cr

Market figures: Delayed · as reported by Yahoo Finance. Financials as reported in company filings.

Ask MarketChacha about ENTERO

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

Period	Revenue	Net profit	Net margin
FY2026	₹6,591 Cr	₹115 Cr	1.7%
FY2025	₹5,096 Cr	₹95 Cr	1.9%
FY2024	₹3,922 Cr	₹39 Cr	1.0%
FY2023	—	₹-12 Cr	—

Quarterly

Period	Revenue	Net profit	Net margin
2026Q1	₹1,910 Cr	₹28 Cr	1.5%
2025Q4	₹1,707 Cr	₹28 Cr	1.6%
2025Q3	₹1,571 Cr	₹32 Cr	2.0%
2025Q2	₹1,404 Cr	₹28 Cr	2.0%

Figures as reported, in ₹ (crore). Source: Yahoo Finance.

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.